Regulatory peptides and their antagonists in nephropathies

被引:4
作者
Wolf, G [1 ]
Panzer, U [1 ]
Stahl, RAK [1 ]
机构
[1] Univ Hamburg, Hosp Eppendorf, Dept Med, Div Nephrol & Osteol, D-20246 Hamburg, Germany
关键词
D O I
10.1097/00041552-200005000-00005
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Many peptides influence renal function and structure in physiological and pathophysiological situations, Bioactive peptides that regulate renal function and structure encompass various substances including vasopeptides, growth factors, cytokines and peptide hormones, We highlight some novel concepts indicating that the vasoactive peptides angiotensin II and endothelin-1 play a major role in the progression of renal disease. These effects may be amplified by reduced concentration of counteracting natriuretic peptides. in addition, recent evidence suggests that peptides such as leptin, previously not considered to exert any renal effects, may be involved in renal pathophysiology under certain conditions. One of the most imperative tasks in nephrology is to develop innovative strategies to slow the progression of chronic renal disease. interference with the renal action of bioactive peptides will certainly be part of this strategy. Curr Opin Nephrol Hypertens 9:233-239. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:233 / 239
页数:7
相关论文
共 70 条
[1]   Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year [J].
Benigni, A ;
Bruzzi, I ;
Mister, M ;
Azzollini, N ;
Gaspari, F ;
Perico, N ;
Gotti, E ;
Bertani, T ;
Remuzzi, G .
KIDNEY INTERNATIONAL, 1999, 55 (02) :674-685
[2]   Endothelin antagonists [J].
Benigni, A ;
Remuzzi, G .
LANCET, 1999, 353 (9147) :133-138
[3]   Prevention of chronic renal allograft rejection in rats with an oral endothelin A receptor antagonist [J].
Braun, C ;
Conzelmann, T ;
Vetter, S ;
Schaub, M ;
Back, WE ;
Yard, B ;
Kirchengast, M ;
Tullius, SG ;
Schnülle, P ;
van der Woude, FJ ;
Rohmeiss, P .
TRANSPLANTATION, 1999, 68 (06) :739-746
[4]  
Budisavljevic Milos N., 1999, Journal of the American Society of Nephrology, V10, p446A
[5]   Losartan decreases plasma levels of TGF-β1 in transplant patients with chronic allograft nephropathy [J].
Campistol, JM ;
Iñigo, P ;
Jimenez, W ;
Lario, S ;
Clesca, PH ;
Oppenheimer, F ;
Rivera, F .
KIDNEY INTERNATIONAL, 1999, 56 (02) :714-719
[6]   C-type natriuretic peptide inhibits mesangial cell proliferation and matrix accumulation in vivo [J].
Canaan-Kühl, S ;
Ostendorf, T ;
Zander, K ;
Koch, KM ;
Floege, J .
KIDNEY INTERNATIONAL, 1998, 53 (05) :1143-1151
[7]  
Cordonnier DJ, 1999, J AM SOC NEPHROL, V10, P1253
[8]  
de Weerth A, 1998, EUR J CLIN INVEST, V28, P592
[9]   Regulation of proximal tubular osteopontin in experimental hydronephrosis in the rat [J].
Diamond, JR ;
Kreisberg, R ;
Evans, R ;
Nguyen, TA ;
Ricardo, SD .
KIDNEY INTERNATIONAL, 1998, 54 (05) :1501-1509
[10]   Hyperleptinemia in uremic patients undergoing conservative management, peritoneal dialysis, and hemodialysis:: A comparative analysis [J].
Fontán, MP ;
Rodríguez-Carmona, A ;
Cordido, F ;
García-Buela, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (05) :824-831